Skip to main navigation
TCR² Therapeutics
  • Our Science
  • Our Pipeline
  • Patients
    • Clinical Trials
    • Expanded Access Program
  • Investors
    • Press Releases
    • SEC Filings
  • Get in Touch
  • Join Us
  • Home
  • Our Science
  • Our Pipeline
  • Patients
    ►
      ◄ Back
    • Clinical Trials
    • Expanded Access Program
  • Investors
    ►
      ◄ Back
    • Press Releases
    • SEC Filings
  • Get in Touch
  • Join Us

Investors & Media

SEC Filing Details

Document Details

Form
POSASR
Filing Date
Mar 22, 2022
Document Date
Mar 22, 2022
Form Description
POSASR
Filing Group
Other
Company
TCR2 Therapeutics
Issuer
TCR2 THERAPEUTICS INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Our Science
  • Our Pipeline
  • Patients
  • Investors
  • Get in Touch
  • Join Us
  • Privacy Policy
  • Disclaimer
  • Terms of Use
  • Supply Terms

© 2023 TCR² Therapeutics. All rights reserved.

TCR² Therapeutics